Remote Jobs at F. Hoffmann-La Roche Ltd (Roche)
F. Hoffmann-La Roche Ltd (Roche) is a healthcare and biotechnology company.
What They Do
Roche aims to prevent, diagnose, and treat diseases using medical advances. The company specializes in oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders.
Roche occasionally offers remote jobs. Some remote jobs may be location-specific.
Remote Jobs
At the time of our research, we discovered a remote job for a director global healthcare econ & value.
Remote Tools Used
Research did not uncover any remote tools used by Roche.
Research Findings
- Our researchers found one full-time remote job with Roche
- We learned Roche may require travel for some jobs
- According to our research, Roche promotes a professional working environment
- We noted Roche is a results-oriented workplace
- Application method: Applicant Tracking Software
Join Our Community Today
- Largest screened remote jobs database.
- Save time. We research the jobs for you.
- New remote jobs posted daily.
- Search our database and start applying.
Headquarters Basel, Switzerland
Founded 1896
Website www.roche.com
Type Employer
Wikipedia F. Hoffmann-La Roche Ltd (Roche)
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2% 1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth
FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or
Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS
Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys® pTau217 plasma biomarker test is being developed as part of an ongoing partnership